Effect of insulin-like growth factor-I on nitrogen balance and intestinal galactose transport in rats with moderate liver cirrhosis

No abstract is available for this paper.

• Publication year

  2003

• Venue

  British Journal of Nutrition

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1079/BJN2003974PMID 14667186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticatabolic Effect of Branched‐Chain Amino Acid‐Enriched Solutions in Patients with Liver Cirrhosis

  2007cited by this paper
• Serum insulin-like growth factor I regulates brain amyloid-β levels

  2002cited by this paper
• Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.

  2002cited by this paper
• Insulin-like growth factor-I: compartmentalization within the somatotropic axis?

  2002cited by this paper
• Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

  2001cited by this paper
• Essentiality of selenium in the human body: relationship with different diseases.

  2000cited by this paper
• Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions*

  2000cited by this paper
• Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I.

  2000influential reference
• Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis

  2000cited by this paper
• Insulin‐like growth factor‐I reverts testicular atrophy in rats with advanced cirrhosis

  2000cited by this paper
• Regulation of the insulin-like growth factor axis by increasing cell number in intestinal epithelial (IEC-6) cells.

  1999cited by this paper
• The Role of Insulin-Like Growth Factors in Small Intestinal Cell Growth and Development

  1999cited by this paper
• Nutritional issues in cirrhosis and liver transplantation.

  1999cited by this paper
• Hepatic energy and substrate metabolism: a possible metabolic basis for early nutritional support in cirrhotic patients.

  1998cited by this paper
• The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.

  1998cited by this paper
• Daily energy and substrate metabolism in patients with cirrhosis

  1998cited by this paper
• IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats.

  1998cited by this paper
• IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats.

  1998cited by this paper
• Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation.

  1998cited by this paper
• Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis.

  1997influential reference
• Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I.

  1997influential reference
• Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis.

  1997influential reference
• Hepatology: A Textbook of Liver Disease

  1997cited by this paper
• Expression of IGF-I and IGF-binding protein genes in cirrhotic liver.

  1996cited by this paper
• Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.

  1995cited by this paper
• Regulation of nutrient metabolism and energy expenditure.

  1995cited by this paper
• Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults.

  1995cited by this paper
• Overview of proposed mechanisms for the hypocholesterolemic effect of soy.

  1995cited by this paper
• Complications of chronic liver disease.

  1995cited by this paper
• Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

  1995influential reference
• Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans.

  1994cited by this paper
• Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women.

  1993cited by this paper
• Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosis.

  1993cited by this paper
• The thermogenic and metabolic effects of food in liver cirrhosis: consequences on the storage of nutrients and the hormonal counterregulatory response.

  1992cited by this paper
• Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis.

  1992cited by this paper
• Nutritional therapy in patients with liver cirrhosis.

  1992cited by this paper
• The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.

  1992cited by this paper
• [Nutritional therapy in patients with liver cirrhosis].

  1992cited by this paper
• Energy expenditure and substrate oxidation in patients with cirrhosis: The impact of cause, clinical staging and nutritional state

  1992cited by this paper
• Disordered Energy and Protein Metabolism in Liver Disease

  1991cited by this paper
• Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis

  1991cited by this paper
• In micronodular cirrhosis, hepatocytes retain a normal C‐25 hydroxylation capacity toward vitamin D3: A study using the rat carbon tetrachloride–induced cirrhotic model

  1991cited by this paper
• Nutritional Therapies in Liver Disease

  1991cited by this paper
• Decreased hepatic glycogen content and accelerated response to starvation in rats with carbon tetrachloride–induced cirrhosis

  1991cited by this paper
• Steatorrhoea in Cirrhosis: Effect of Ursodeoxycholic Acid Administration

  1990cited by this paper
• Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites.

  1989cited by this paper
• Carbon tetrachloride-induced experimental cirrhosis in the rat: a reappraisal of the model.

  1989cited by this paper
• Problems with animal models of chronic liver disease: Suggestions for improvement in standardization

  1989influential reference
• Glucose metabolism in cirrhosis: a review with some perspectives for the future.

  1989cited by this paper
• Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.

  1989cited by this paper
• Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum‐induced fibrotic rat liver

  1988cited by this paper
• Bioavailability of zinc from zinc-histidine complexes. II. Studies on patients with liver cirrhosis and the influence of the time of application.

  1987cited by this paper
• Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis.

  1984cited by this paper
• Hepatology: A textbook of liver disease:By D. Zakim and T. D. Boyer. 1318 pp., $95.00. W. B. Saunders Company, Philadelphia, Pennsylvania, 1982

  1983cited by this paper
• Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting.

  1982cited by this paper
• Principles and methods of toxicology

  1982cited by this paper
• Phenobarbitone-induced enlargement of the liver in the rat: its relationship to carbon tetrachloride-induced cirrhosis.

  1981cited by this paper
• Malnutrition and immuno-incompetence in patients with liver disease.

  1980cited by this paper
• Method for successive absorptions with intestinal perfusion in vivo.

  1979cited by this paper
• Liver disease and nutrition.

  1978cited by this paper
• Somatomedin production in normal adults and cirrhotic patients.

  1977cited by this paper
• Removal of yolk from oyster eggs by Soxhlet extraction for clear chromosome preparations.

  1968cited by this paper

• Moderate glucose control results in less negative nitrogen balances in medical intensive care unit patients: a randomized, controlled study

  2012cites this paper
• Effects of insulin‐like growth factor‐I administration on in vivo regulation of urea synthesis in normal subjects and patients with cirrhosis

  2011cites this paper
• Genes and Nutrition

  2010cites this paper
• Intestinal beneficial effects of kefir-supplemented diet in rats

  2007cites this paper
• Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.

  2004cites this paper